Jade Biosciences (JBIO) Change in Cash (2020 - 2026)
Jade Biosciences (JBIO) posted Change in Cash of -$33.4 million for Q1 2026, down 187.01% on a QoQ basis from $38.3 million in Q4 2025, and down 71.42% year-over-year from -$116.7 million in Q1 2025.
Jade Biosciences (JBIO) Change in Cash (2020 - 2026) Analysis & Trends
Jade Biosciences' Change in Cash history runs 7 years deep, the most recent figure standing at -$33.4 million for Q1 2026.
- Quarterly Change in Cash fell 71.42% year-over-year to -$33.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 96.26% YoY) and the FY2025 annual result came in at $19.1 million, up 85.69% from the prior year.
- Change in Cash was -$33.4 million for Q1 2026 at Jade Biosciences, down from $38.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $171.0 million in Q2 2025 and bottomed at -$170.8 million in Q3 2025.
- A 5-year average of $6.1 million and a median of -$2.9 million in 2022 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 5148.53% in 2023, while the deepest fall reached 39395.45% in 2023.
- Jade Biosciences' Change in Cash stood at -$22000.0 in 2022, then slumped by 39395.45% to -$8.7 million in 2023, then soared by 898.55% to $69.4 million in 2024, then tumbled by 44.76% to $38.3 million in 2025, then plunged by 187.01% to -$33.4 million in 2026.
- Business Quant data shows JBIO's Change in Cash at -$33.4 million in Q1 2026, $38.3 million in Q4 2025, and -$170.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | -33.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.35 Mn |
| Dec 31, 2025 | 38.33 Mn |
| Sep 30, 2025 | -170.84 Mn |
| Jun 30, 2025 | 171.01 Mn |
| Mar 31, 2025 | -19.46 Mn |
| Dec 31, 2024 | 69.39 Mn |
| Sep 30, 2024 | 87.97 Mn |
| Mar 31, 2024 | -14.37 Mn |
| Dec 31, 2023 | -8.69 Mn |
| Sep 30, 2023 | -28.72 Mn |
| Jun 30, 2023 | 34.33 Mn |
| Mar 31, 2023 | 4.17 Mn |
| Dec 31, 2022 | -22,000.00 |
| Sep 30, 2022 | -5.04 Mn |
| Jun 30, 2022 | -680,000.00 |
| Mar 31, 2022 | -26.06 Mn |
| Dec 31, 2021 | -126.68 Mn |
| Sep 30, 2021 | 121.73 Mn |
| Jun 30, 2021 | 50.51 Mn |
| Mar 31, 2021 | 4.07 Mn |